Stay updated on Pfizer Press Releases
Sign up to get notified when there's something new on the Pfizer Press Releases page.

Latest updates to the Pfizer Press Releases page
- CheckyesterdayChange DetectedA new press release announces Pfizer’s exclusive licensing agreement with Starna Therapeutics for autoimmune diseases. The listing for Pfizer’s October 1, 2026, Phase 2 atopic dermatitis study of Tilrekimig is no longer present.SummaryDifference2%

- Check8 days agoChange DetectedThe Pfizer newsroom page displays its press release archive, including dated headlines, category filters, and footer information.SummaryDifference100%

- Check15 days agoChange DetectedThe press release archive adds announcements on Pfizer’s third-quarter 2026 results and raised guidance, as well as Cecile Guegan’s appointment as chief financial officer. A listing for a webcast about Pfizer’s participation in a healthcare conference is no longer shown.SummaryDifference36%

- Check22 days agoChange DetectedThe press-release list now features October 2026 announcements about ELREXFIO’s Phase 3 results and TALZENNA plus XTANDI’s FDA approval. Older August 2026 releases about Pfizer’s Lyme disease vaccine candidate and the updated COVID-19 vaccine are no longer shown.SummaryDifference4%

- Check29 days agoChange DetectedThe press-release listing now includes Pfizer’s report of robust Phase 2 results for its 25-valent pediatric pneumococcal vaccine candidate. It no longer lists the release reporting second-quarter results and updated 2026 revenue guidance.SummaryDifference0.9%

- Check36 days agoChange DetectedA new October 14, 2026 press release highlights Pfizer’s clinical advancements across infectious diseases at IDWeek. The July 2026 LITFULO Phase 3 results announcement and its related listing labels are no longer shown.SummaryDifference1%

Stay in the know with updates to Pfizer Press Releases
Enter your email address, and we'll notify you when there's something new on the Pfizer Press Releases page.